home All News open_in_new Full Article
Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial
today 3 h. ago attach_file Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Society
attach_file
Other
attach_file
Economics
attach_file
Events
attach_file
Science
attach_file
Events
attach_file
Economics
attach_file
Other
attach_file
Events
attach_file
Other
attach_file
Events
attach_file
Other
ID: 1679779824